Epigenetics and Ovarian Cancer
Kenneth P. Nepbew,Curt Baleh,Shu Zhang,Tim H-M. Huang
DOI: https://doi.org/10.1007/978-0-387-98094-2_6
2009-01-01
Abstract:Epigenetics is a broad term that refers to all stably heritable alterations in gene expression that occur without changes in DNA base sequence. Epigenetic phenomena include deoxycytosine methylation, histone protein modifications, nucleosome position effects on DNA, and gene regulation by noncoding RNA molecules (Fig. 6.1); the overall epigenetic state corresponding with a specific cell phenotype is referred to as an ‘‘epigenome.’’ The Human Genome Project, completed in 2003, has provided a wealth of data regarding the relationship of DNA sequence to human health, and one interesting outcome of that project was the observation that humans possess far fewer genes than previously predicted. That vast underestimation of human genes suggested amuch greater role for phenotype-specific gene regulation by other mechanisms, including epigenetic modifications. Consequently, a Human Epigenome Project, an international public/private consortium, has now been initiated to provide a set of normal, reference epigenomes to permit study of the role of epigenetics in biological processes such as differentiation, proliferation, and various disease states, including cancer. To date, the best-studied epigenetic process is methylation of deoxycytosine, usually located within the dinucleotide CpG, and catalyzed by enzymes known as DNA methyltransferases (DNMTs). DNA methylation is strongly correlated with gene silencing, and in normal cells, heterochromatin and the inactive female X chromosome are extensively methylated. This modification also occurs within repeat elements, where it is believed to silence potentially harmful transposable elements. Aside from heterochromatin and repeats, distinct regions, usually within 50 untranslated regions and the first exons of genes, are normally protected from this modification. It is now well established, however, that these localized ‘‘CpG islands’’ become increasingly hypermethylated during tumor advancement